We are very sorry but it looks like you are using an outdated browser. We strongly recommend updating to a modern browser.
More information about your browser and how to update

Else Kröner-Fresenius Graduiertenkolleg PhD positions

This job ad is out of date. Find related Jobs here.

3 PhD positions available within the Else Kröner-Fresenius Research Training Group (EKG-GK) “Eicosanoid and sphingolipid pathways in inflammation, cancer and vascular diseases”, starting July 1st, 2016.

The now available PhD projects in Frankfurt are:
·  Identification of the role of Cyp2c44- and sEH-derived lipids in lymphangiogenesis and tumour metastasis (Prof. Dr. Ingrid Fleming)
·  miR-574 decoy as novel mechanism in the control of prostaglandin formation (Prof. Dr. Dieter Steinhilber)
· Role of sphingosine-1-phosphate (S1P) as regulator of the blood brain barrier in health and in brain diseases (Prof. Dr. Josef Pfeilschifter, Dr. Waltraud Pfeilschifter)
· Sphingolipid-dependent modulation of the TLR and IL-1/TIR signaling and its role for antigen-specific cytotoxic T lymphocyte anti-cancerogenic activity  (Prof. Dr. Heinfried Radeke)

The EKF-GK is an international research training group at the Goethe University Frankfurt and the Karolinska Institute in Stockholm and is funded by the Else Kröner-Fresenius-Stiftung.  The focus of this research training group is on intensifying the understanding of the physiological and pathophysiological roles of eicosanoids and sphingolipids in inflammatory processes, cancer and vascular diseases. The molecular mechanisms of actions will be investigated using complementary approaches (chemical, biochemical, molecular, pharmacological, physiological and preclinical). 
The Else Kröner-Fresenius Research Training Group is embedded in the Graduate Centre FIRST (Frankfurt International Research School for Translational Biomedicine) of the Goethe Graduate Academy (GRADE).   FIRST provides postgraduate education in all aspects of translationals biomedicine with a focus on the processes involved in drug research and development.
Candidates should already possess a first class MSc (biology, pharmacy or related discipline) or an MD degree.  Applications consisting of a cover letter indicating motivation and project references as well as a full curriculum vitae containing a brief summary of previous research projects, together with copies of all relevant university certificates should be sent by email to Dr. Brigitte Held (held@pharmchem.uni-frankfurt.de).  Hard copy version can be to the postal address:  Dr. Brigitte Held, Institut für Pharmazeutische Chemie, Goethe Universität Frankfurt, Max-von-Laue-Str. 9, D - 60438 Frankfurt.  Incomplete applications will not be considered.
The application deadline is May 22nd, 2016.  Short listed applications will be required to attend a selection workshop in Frankfurt.
Stipends will be paid according to the rules of the Deutsche Forschungsgemeinschaft (DFG).

For further information on the projects as well as FIRST, please visit:  www.first-gradschool.de

Contact detail

How to apply:
by email
Send application to
Dr. Brigitte Held
FIRST, c/o Institut für Pharm. Chemie
Goethe Universität
Max-von-Laue-Str. 9
60438 Frankfurt a.M.
Email:  held@pharmchem.uni-frankfurt.de

Job profile

Working hours
Contract duration
Type of job
PhD Project
Work experience
job experience is not required
Germany (Hessen)
Working place
60438 Frankfurt a. M.
Area of expertise
Biology & Life Sciences, Pharmaceutics